Results for tag: "Antithrombogenic Coating"

The Antithrombogenic Coating market is a subset of the Medical Device Coatings market, which is used to reduce the risk of thrombosis and other clotting-related issues. Antithrombogenic coatings are applied to medical devices such as catheters, stents, and other implantable devices to reduce the risk of clotting and thrombosis. These coatings are designed to reduce the risk of clotting by providing a smooth, non-thrombogenic surface that is resistant to platelet adhesion. The coatings also reduce the risk of infection by providing a barrier between the device and the patient's body. The Antithrombogenic Coating market is driven by the increasing demand for medical devices and the need for improved patient safety. The market is expected to grow in the coming years due to the increasing prevalence of chronic diseases and the need for improved medical device coatings. Some of the major companies in the Antithrombogenic Coating market include Surmodics, Inc., Biocoat, Inc., Specialty Coating Systems, Inc., and Advanced Medical Solutions Group plc. Show Less Read more